FDA Inspection 863862 — ReproTech, Ltd.

ReproTech, Ltd. — FEI 3003651454

The FDA completed an inspection of ReproTech, Ltd. on January 29, 2014 in Saint Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 29, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Saint Paul, MN (United States)